-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Downgrades Molina Healthcare to Neutral, Raises Price Target to $375

Benzinga·04/15/2025 11:36:31
Listen to the news
Baird analyst Michael Ha downgrades Molina Healthcare (NYSE:MOH) from Outperform to Neutral and raises the price target from $331 to $375.